PEAK PHARMACEUTICALS, INC. — Income Charts
27 quarters of history · ending 2017-06-30 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$0
Cost of Revenue
$0
Gross Profit
$0
R&D
$908
D&A
$0
Operating Income↓-248.8% -$24K
$-15K
EBITDA↓-248.8% -$24K
$-15K
Interest Expense
$598
Other Income/Expense
$0
Pretax Income↑+37.7% +$2K
$-4K
Tax Provision
$0
Net Income↓-248.8% -$24K
$-15K
Gross Margin
37.5%
Operating Margin
-718.3%
Net Margin
-694.5%
Effective Tax Rate
0.0%
ETR (Continuing Operations)↑+0.0pts
0.0%
ETR Federal Statutory↑+3366.0pts
3400.0%
ETR State + Local (pp)↑+306.9pts
310.0%
ETR Foreign Differential (pp)↑+0.0pts
-39.8%
Operating Lease Cost↓-100.0% -$6K
$0
Revenue YoY Variation
-100.0%
Income YoY Variation↓-350.8pts
-248.8%
Revenue QoQ Variation
-100.0%
Income QoQ Variation↓-68.4pts
-167.7%